SCHEDULE 13G/A

Aclaris Therapeutics Inc

Common Stock, par value $0.00001 per share · CUSIP: 00461U105

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Millennium Management LLC

  Shares: 3,837,380.00 · Class: 3.5%

• Millennium Group Management LLC

  Shares: 3,837,380.00 · Class: 3.5%

• Israel A. Englander

  Shares: 3,837,380.00 · Class: 3.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.